Criminal and civil actions filed against Aegerion Pharmaceuticals Inc.
Aegerion Pharmaceuticals agreed to plead guilty in the U.S. District Court for the District of Massachusetts to two misdemeanor counts of violating the Federal Food, Drug, and Cosmetic Act involving the introduction of misbranded Juxtapid (lomitapide) into interstate commerce. September 22, 2017